PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
Auto Draft
Auto Draft
Elrig
Auto Draft
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Wallonia

 
Wallonia is one of Europe’s most dynamic life sciences regions, home to a rich ecosystem spanning multinational leaders such as GSK and UCB through to innovative SMEs, spinoffs and specialist service providers across biotech and medtech. AWEX, the Wallonia Export and Investment Agency, is the single point of contact for any company looking to establish or grow its presence in Wallonia, as well as a strategic partner for Wallonian companies expanding internationally. Backed by a network of over 580 companies, universities, incubators and investors in the life sciences sector, we offer tailored support across the full investment and internationalisation journey, from market intelligence and partner identification to financing, R&D incentives and access to world-class capabilities in areas including cell therapy and immuno-oncology. Whether you are considering Wallonia as a base for your European operations or seeking partnerships within our ecosystem, AWEX is here to support you throughout the process.

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC